Proteomic analysis of two metabolic proteins with potential to translocate to plasma membrane associated with tumor metastasis development and drug targets

Journal of Proteome Research

Volumn 12, Issue 4, 2013, Pages 1754-1763

  Xue, Ting ^a   Zhang, Yan ^a   Zhang, Luofu ^a   Yao, Ling ^a   Hu, Xiaofang ^a   Xu, Lisa X ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

breast cancer; drug target; FASN; metastasis; NSDHL; plasma membrane translocation; proteomics

Indexed keywords

FATTY ACID SYNTHASE; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE STEROID DEHYDROGENASE LIKE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOTINYLATION; BREAST CANCER; CELL MEMBRANE; CELL METABOLISM; DRUG TARGETING; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; STRUCTURAL BIOINFORMATICS; TANDEM MASS SPECTROMETRY; TUMOR GROWTH;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MEMBRANE; CHROMATOGRAPHY, LIQUID; FATTY ACID SYNTHASE, TYPE I; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; PROTEIN TRANSPORT; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84875958234     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr301100r     Document Type: Article

References (74)

1. DeSantis, C.; Siegel, R.; Bandi, P.; Jemal, A. Breast cancer statistics, 2011 Ca-Cancer J. Clin. 2011, 61 (6) 409-18
2. Nguyen, D. X.; Bos, P. D.; Massague, J. Metastasis: from dissemination to organ-specific colonization Nat. Rev. Cancer 2009, 9 (4) 274-84
3. Cavallaro, U.; Christofori, G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat. Rev. Cancer 2004, 4 (2) 118-32
4. Paschos, K. A.; Canovas, D.; Bird, N. C. The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis Cell. Signalling 2009, 21 (5) 665-74
5. Zhao, Y. Z., W.; Kho, Y. Proteomic analysis of integral plasma membrane proteins Anal. Chem. 2004, 76 (7) 1817-23
6. Suzuki, M.; Tarin, D. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications Mol. Oncol. 2007, 1 (2) 172-80
7. Aslakson, C. J.; Rak, J. W.; Miller, B. E.; Miller, F. R. Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis Int. J. Cancer 1991, 47 (3) 466-72
8. Aslakson, C. J.; Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res. 1992, 52 (6) 1399-405
9. Yang, J.; Mani, S. A.; Donaher, J. L.; Ramaswamy, S.; Itzykson, R. A.; Come, C.; Savagner, P.; Gitelman, I.; Richardson, A.; Weinberg, R. A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 2004, 117 (7) 927-39
10. Ho, J.; Kong, J. W.; Choong, L. Y.; Loh, M. C.; Toy, W.; Chong, P. K.; Wong, C. H.; Wong, C. Y.; Shah, N.; Lim, Y. P. Novel breast cancer metastasis-associated proteins J. Proteome Res. 2009, 8 (2) 583-94
11. Kischel, P.; Guillonneau, F.; Dumont, B.; Bellahcene, A.; Stresing, V.; Clezardin, P.; De Pauw, E. A.; Castronovo, V. Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells Neoplasia 2008, 10 (9) 1014-20
12. Leth-Larsen, R.; Lund, R.; Hansen, H. V.; Laenkholm, A. V.; Tarin, D.; Jensen, O. N.; Ditzel, H. J. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry Mol. Cell. Proteomics 2009, 8 (6) 1436-49
13. Liang, X.; Zhao, J.; Hajivandi, M.; Wu, R.; Tao, J.; Amshey, J. W.; Pope, R. M. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma J. Proteome Res. 2006, 5 (10) 2632-41
14. Kreunin, P.; Yoo, C.; Urquidi, V.; Lubman, D. M.; Goodison, S. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model Proteomics 2007, 7 (2) 299-312
15. Keller, A. N., A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-92
16. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-58
17. Piersma, S. R.; Fiedler, U.; Span, S.; Lingnau, A.; Pham, T. V.; Hoffmann, S.; Kubbutat, M. H. G.; Jiménez, C. R. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum J. Proteome Res. 2010, 9 (4) 1913-22
18. Kroemer, G.; Pouyssegur, J. Tumor cell metabolism: cancer's Achilles' heel Cancer Cell 2008, 13 (6) 472-82
19. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation Cell 2011, 144 (5) 646-74
20. Martinez-Outschoorn, U. E.; Prisco, M.; Ertel, A.; Tsirigos, A.; Lin, Z.; Pavlides, S.; Wang, C.; Flomenberg, N.; Knudsen, E. S.; Howell, A.; Pestell, R. G.; Sotgia, F.; Lisanti, M. P. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via metabolo-genomics Cell Cycle 2011, 10 (8) 1271-86
21. Chia, S. K.; Wykoff, C. C.; Watson, P. H.; Han, C.; Leek, R. D.; Pastorek, J.; Gatter, K. C.; Ratcliffe, P.; Harris, A. L. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma J. Clin. Oncol. 2001, 19 (16) 3660-8
22. McDonald, P. C.; Winum, J. Y.; Supuran, C. T.; Dedhar, S. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics Oncotarget 2012, 3 (1) 84-97
23. Robertson, N.; Potter, C.; Harris, A. L. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion Cancer Res. 2004, 64 (17) 6160-5
24. Henry, L. A.; S Lee, D. J.; Quinlan, P. R.; Crook, T.; Thompson, A. M.; Reis-Filho, J. S.; Isacke, C. M. Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis Breast Cancer Res. 2010, 12
25. Jean-Philippe Dales, S. G.; Pascal, B.; Florence, D.; Andrac-Meyer, L.; Ramuz, O.; Marie-Noëlle, L.; Allasia, C.; Charpin, C. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas Anat. Pathol. 2003, 119, 374-80
26. Oxmann, D.; H.-F., J.; Stark, A. M.; Hattermann, K.; Yoneda, T.; Mentlein, R. Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype Oncogene 2008, 27, 3567-75
27. Henrikson, K. P.; Salazar, S. L.; Fenton, J. W., 2nd; Pentecost, B. T. Role of thrombin receptor in breast cancer invasiveness Br. J. Cancer 1999, 79 (3-4) 401-6
28. Nierodzik, M. L.; Karpatkin, S. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype Cancer Cell 2006, 10 (5) 355-62
29. Borensztajn, K.; Peppelenbosch, M. P.; Spek, C. A. Coagulation Factor Xa inhibits cancer cell migration via LIMK1-mediated cofilin inactivation Thromb. Res. 2010, 125 (6) e323-8
30. Morris, D. R.; Tiffany K. Ricks, Y. D.; Gullapalli, A.; Breann, L. W.; Trejo, J. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced singaling, migration, and invasion of breast cancer cells Cancer Res. 2006, 66, 307-14
31. Nagaraja, G. M.; Othman, M.; Fox, B. P.; Alsaber, R.; Pellegrino, C. M.; Zeng, Y.; Khanna, R.; Tamburini, P.; Swaroop, A.; Kandpal, R. P. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics Oncogene 2006, 25 (16) 2328-38
32. Diarra-Mehrpour, M.; Arrabal, S.; Jalil, A.; Pinson, X.; Gaudin, C.; Pietu, G.; Pitaval, A.; Ripoche, H.; Eloit, M.; Dormont, D.; Chouaib, S. Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death Cancer Res. 2004, 64 (2) 719-27
33. Cao, W. M.; Murao, K.; Imachi, H.; Yu, X.; Abe, H.; Yamauchi, A.; Niimi, M.; Miyauchi, A.; Wong, N. C.; Ishida, T. A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells Cancer Res. 2004, 64 (4) 1515-21
34. Ha, S. A.; Shin, S. M.; Namkoong, H.; Lee, H.; Cho, G. W.; Hur, S. Y.; Kim, T. E.; Kim, J. W. Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis Clin. Cancer Res. 2004, 10, 8386-95
35. Ghanta, K. S.; Li, D. Q.; Eswaran, J.; Kumar, R. Gene profiling of MTA1 identifies novel gene targets and functions PLoS One 2011, 6 (2) e17135
36. Naoi, Y.; Kishi, K.; Tanei, T.; Tsunashima, R.; Tominaga, N.; Baba, Y.; Kim, S. J.; Taguchi, T.; Tamaki, Y.; Noguchi, S. Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients Breast Cancer Res. Treat. 2011, 128 (3) 633-41
37. Kuhajda, F. P. Fatty acid synthase and cancer: new application of an old pathway Cancer Res. 2006, 66, 12
38. Menendez, J. A. L., R. Fatty acid synthase catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells Arch. Immunol. Ther. Exp. 2004, 52, 414-26
39. Anique Herling, M. K.; Bulik, S.; Holzhütter, H.-G. Enzymatic features of the glucose metabolism in tumor cells FEBS J. 2011, 278, 2436-59
40. Mackay, A.; Tamber, N.; Fenwick, K.; Iravani, M.; Grigoriadis, A.; Dexter, T.; Lord, C. J.; Reis-Filho, J. S.; Ashworth, A. A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines Breast Cancer Res. Treat. 2009, 118 (3) 481-98
41. Hillgartner, F. B.; Salati, L. M.; Goodridge, A. G. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis Physiol. Rev. 1995, 75 (1) 47-76
42. Semenkovich, C. F. Regulation of fatty acid synthase (FAS) Prog. Lipid Res. 1995, 36, 43-53
43. Milgraum, L. Z.; Witters, L. A.; Pasternack, G. R.; Kuhajda, F. P. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma Clin. Cancer Res. 1997, 3 (11) 2115-20
44. Esslimani-Sahla, M.; Thezenas, S.; Simony-Lafontaine, J.; Kramar, A.; Lavaill, R.; Chalbos, D.; Rochefort, H. Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis Int. J. Cancer 2007, 120 (2) 224-9
45. Liu, X. Y.; Dangel, A. W.; Kelley, R. I.; Zhao, W.; Denny, P.; Botcherby, M.; Cattanach, B.; Peters, J.; Hunsicker, P. R.; Mallon, A. M.; Strivens, M. A.; Bate, R.; Miller, W.; Rhodes, M.; Brown, S. D.; Herman, G. E. The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase Nat. Genet. 1999, 22 (2) 182-7
46. Konig, A.; Happle, R.; Bornholdt, D.; Engel, H.; Grzeschik, K. H. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome Am. J. Med. Genet. 2000, 90 (4) 339-46
47. Browning, D. R.; Martin, R. M. Statins and risk of cancer: a systematic review and metaanalysis Int. J. Cancer 2007, 120 (4) 833-43
48. Brown, A. J. Cholesterol, statins and cancer Clin. Exp. Pharmacol. Physiol. 2007, 34 (3) 135-41
49. Laezza, C.; Malfitano, A. M.; Proto, M. C.; Esposito, I.; Gazzerro, P.; Formisano, P.; Pisanti, S.; Santoro, A.; Caruso, M. G.; Bifulco, M. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells Endocr.-Relat. Cancer 2010, 17 (2) 495-503
50. Borgquist, S.; Jogi, A.; Ponten, F.; Ryden, L.; Brennan, D. J.; Jirstrom, K. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer Breast Cancer Res. 2008, 10 (5) R79
51. Glynn, S. A.; O'Sullivan, D.; Eustace, A. J.; Clynes, M.; O'Donovan, N. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells BMC Cancer 2008, 8, 9
52. Scharpf, R. B.; Iacobuzio-Donahue, C. A.; Cope, L.; Ruczinski, I.; Garrett-Mayer, E.; Lakkur, S.; Campagna, D.; Parmigiani, G. Cross-platform comparison of two pancreatic cancer phenotypes Cancer Inf. 2010, 9, 257-64
53. Narayan, G.; Bourdon, V.; Chaganti, S.; Arias-Pulido, H.; Nandula, S. V.; Rao, P. H.; Gissmann, L.; Durst, M.; Schneider, A.; Pothuri, B.; Mansukhani, M.; Basso, K.; Chaganti, R. S.; Murty, V. V. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes Genes, Chromosomes Cancer 2007, 46 (4) 373-84
54. Wang, Y.; Kuhajda, F. P.; Sokoll, L. J.; Chan, D. W. Two-site ELISA for the quantitative determination of fatty acid synthase Clin. Chim. Acta 2001, 304 (1-2) 107-15
55. Wang, Y. Y.; Kuhajda, F. P.; Li, J.; Finch, T. T.; Cheng, P.; Koh, C.; Li, T.; Sokoll, L. J.; Chan, D. W. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer J. Exp. Ther. Oncol. 2004, 4 (2) 101-10
56. Wang, Y.; Kuhajda, F. P.; Li, J. N.; Pizer, E. S.; Han, W. F.; Sokoll, L. J.; Chan, D. W. Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients Cancer Lett. 2001, 167 (1) 99-104
57. Goodman, J. M. Demonstrated and inferred metabolism associated with cytosolic lipid droplets J. Lipid Res. 2009, 50 (11) 2148-56
58. Ohashi, M.; Mizushima, N.; Kabeya, Y.; Yoshimori, T. Localization of mammalian NAD(P)H steroid dehydrogenase-like protein on lipid droplets J. Biol. Chem. 2003, 278 (38) 36819-29
59. Caldas, H.; Herman, G. E. NSDHL, an enzyme involved in cholesterol biosynthesis, traffics through the Golgi and accumulates on ER membranes and on the surface of lipid droplets Hum. Mol. Genet. 2003, 12 (22) 2981-91
60. Zweytick, D.; Athenstaedt, K.; Daum, G. Intracellular lipid particles of eukaryotic cells Biochim. Biophys. Acta 2000, 1469 (2) 101-20
61. Staubach, S.; Hanisch, F. G. Lipid rafts: signaling and sorting platforms of cells and their roles in cancer Expert Rev. Proteomics 2011, 8 (2) 263-77
62. Yamaguchi, H.; Takeo, Y.; Yoshida, S.; Kouchi, Z.; Nakamura, Y.; Fukami, K. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells Cancer Res. 2009, 69 (22) 8594-602
63. Di Vizio, D.; Adam, R. M.; Kim, J.; Kim, R.; Sotgia, F.; Williams, T.; Demichelis, F.; Solomon, K. R.; Loda, M.; Rubin, M. A.; Lisanti, M. P.; Freeman, M. R. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase Cell Cycle 2008, 7 (14) 2257-67
64. Twiddy, A. L.; Leon, C. G.; Wasan, K. M. Cholesterol as a potential target for castration-resistant prostate cancer Pharm. Res. 2011, 28 (3) 423-37
65. Gronberg, H. Prostate cancer epidemiology Lancet 2003, 361 (9360) 859-64
66. Maranhao, R. C. Artifical LDL: A new method for treatment of cancer. Unpublished work, 1995.
67. Weber, G. F. Why does cancer therapy lack effective anti-metastasis drugs? Cancer Lett. 2013, 328 (2) 207-11
68. Hopkins, A. L.; Groom, C. R. The druggable genome Nat. Rev. Drug Discovery 2002, 1 (9) 727-30
69. Benderra, Z.; Trussardi, A.; Morjani, H.; Villa, A. M.; Doglia, S. M.; Manfait, M. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein Eur. J. Cancer 2000, 36 (3) 428-34
70. Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C. C.; Dantis, L.; Sklarin, N. T.; Seidman, A. D.; Hudis, C. A.; Moore, J.; Rosen, P. P.; Twaddell, T.; Henderson, I. C.; Norton, L. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer J. Clin. Oncol. 1996, 14 (3) 737-44
71. Cobleigh, M. A.; Vogel, C. L.; Tripathy, D.; Robert, N. J.; Scholl, S.; Fehrenbacher, L.; Wolter, J. M.; Paton, V.; Shak, S.; Lieberman, G.; Slamon, D. J. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease J. Clin. Oncol. 1999, 17 (9) 2639-48
72. Vogel, C. L.; Cobleigh, M. A.; Tripathy, D.; Gutheil, J. C.; Harris, L. N.; Fehrenbacher, L.; Slamon, D. J.; Murphy, M.; Novotny, W. F.; Burchmore, M.; Shak, S.; Stewart, S. J.; Press, M. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer J. Clin. Oncol. 2002, 20 (3) 719-26
73. Menendez, J. A.; Vellon, L.; Lupu, R. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells Med. Hypotheses 2005, 64 (5) 997-1001
74. Swinnen, J. V.; Van Veldhoven, P. P.; Timmermans, L.; De Schrijver, E.; Brusselmans, K.; Vanderhoydonc, F.; Van de Sande, T.; Heemers, H.; Heyns, W.; Verhoeven, G. Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains Biochem. Biophys. Res. Commun. 2003, 302 (4) 898-903